Caitlyn Fitzpatrick

A fair amount of women who are diagnosed with gestational diabetes take active measures to lose weight – but what clinical outcomes does that have?

Vitamin D and diabetes have a rocky relationship, but new insight was revealed at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana.

What happens when a patient with type 2 diabetes uses both a potassium (K)-sparing agent and sodium-glucose co-transporter 2 (SGLT2) inhibitor at the same time?

Statistics coming from controlled trials can be challenging to apply to the real-world. But a new study assessing the use of dapagliflozin for type 2 diabetes in real clinical use yielded important insight.

New research presented at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana makes a case for autologous transplantation.

Pig cell transplantation could take the place of a blood glucose level-improving surgery for patients with type 1 diabetes.

A new test created by researchers at the University of California has cut the number of hepatitis C (HCV) diagnosis testing steps in half – meaning going from two steps to one.

The combination of nebivolol/valsartan (Byvalson) lowers blood pressure better than either drug by themselves.

In an ideal world, there would be a vaccine against the human immunodeficiency virus (HIV). An improved animal model developed by researchers from the Perelman School of Medicine at the University of Pennsylvania could one day make a vaccine a reality.

A migraine diagnosis in women could mean an elevated risk of cardiovascular disease, as well as a higher risk of dying from such conditions.

Individual trials have shown various benefits associated with fingolimod (Gilenya) for relapsing-remitted multiple sclerosis (RRMS), but its consistency across studies has not been fully understood.

Fingolimod (Gilenya) is an immunosuppressant used to treat multiple sclerosis, but improvements with disability have been unsteady with this drug.

Country music artist, Clay Walker – who is well-known for his hit songs “She Won’t Be Lonely Long†and “Live Until I Die" – was diagnosed with a relapsing form of multiple sclerosis (MS) at the age of 26.

“Disabled people aren’t sexually attractive†is just one real quote – and myth – from someone living with multiple sclerosis.

Marijuana and alcohol – studies suggest that one of these substances helps patients with multiple sclerosis while the other can contribute to comorbidities.

Lifestyle factors and multiple sclerosis is a two-way street; but what does that mean for practicing physicians? Allen Bowling, MD, PhD, explains at the 2016 Annual Meeting of the Consortium of Multiple Sclerosis Center (CMSC) in National Harbor, Maryland.

Perfecting an exercise regimen on an individual basis for people with multiple sclerosis is no easy task, as described at the 2016 Annual Meeting of the Consortium of Multiple Sclerosis Center (CMSC) in National Harbor, Maryland.

A change in appetite may not be a huge red flag in most people, but in patients with multiple sclerosis, it could have a larger meaning.

To date, there is no treatment approved by the US Food and Drug Administration (FDA) for primary progressive multiple sclerosis. But a promising treatment could change that regardless of apparent skin reactions.

Disease-modifying therapies (DMTs) help reduce relapses in people with multiple sclerosis. While options have expanded, little is known about which one has the greatest effectiveness.

A phase III study that examined teriflunomide (Aubagio) in a subtype of patients with multiple sclerosis was presented at the 2016 Annual Meeting of the Consortium of Multiple Sclerosis Center (CMSC) in National Harbor, Maryland.

There are various disease-modifying treatment (DMT) options for patients with relapsing-remitting multiple sclerosis (RRMS). But how much do neurologists and patients agree on the first-line course?

As obesity becomes a growing problem, doctors are turning to weight loss surgeries to help their patients return to a healthy quality of life. Work is being done to make these procedures as non-invasive as possible to help with the recovery and postoperative times.

The MD Magazine editors rounded up the 10 best stories from May – did you read them all?

As medications for hepatitis C become more widely used, studies are being done to see how effective these treatments are when used in combination.

Pain medications can often cause side effects such as dizziness and sleepiness; but little do pregnant women know that they could be at risk for birth defects when taking pregabalin.

The development of new medications for any condition requires attention to detail in a number of areas, especially safety and efficacy. A recent drug developed for irritable bowel syndrome (IBS) looked to be effective in both areas prior to its approval.

As more women take leadership roles in gastroenterology and , it can go a long way in helping to bridge the gender gap in that other specialties in medicine.

As with many areas of medicine, the ratio of male doctors in gastroenterology to female counterparts is considerable – although work is being done to lessen that gap across the field.

As with all surgical procedures, there are risks that come with gastric bypass surgery. While the procedure itself is not new, there is work being done to make it more effective and longer lasting for patients who utilize this valuable weight loss option.